Quantum-Si incorporated

NASDAQ:QSI

Biotechnology

Healthcare
$1.07 +5.02%

+$0.05 today

Market cap
$213.79M
Beta
3.17
P/E (TTM)
-2.1
EPS (TTM)
-$0.48
52W Low $0.69High $3.10

Volume 10.47M

Average 5.64M

QSI Pre-Tax Margin

Income before tax as a percentage of revenue.

Quantum-Si incorporatedNASDAQ: QSI

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin narrows to -8446.9%

Pre-tax margin was -8446.9% in Q1 FY2026, down 6169.2 pp from a year earlier. On a trailing-twelve-month basis it was -5609.9%, down 2686.5 pp year over year.

Context

  • Pre-tax margin widened in 1 of the last 2 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-8446.9%-4543.8 pp QoQ
Last fiscal yearDec 2025
-4157.7%-856.5 pp YoY
LTMMar 2026
-5609.9%-2686.5 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-6169.2 pp——
1 year-856.5 pp——
3 years———
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-4157.7%
Year-over-year change
-856.5pp

Pre-Tax Margin vs competitors

How QSI compares with its peers on the latest reported figures

  • QSI's LTM Mar 2026 pre-tax margin of -5609.9% is the 3rd highest of the 4 companies compared; the peer median is -311.3%.
  • Its year-over-year change of -2686.5 pp is the lowest of 4, against a peer median of +2289.7 pp.
QSI Competitors Peer median
Pre-Tax Margin for QSI and competitors
Company Period LTM level YoY 3-year change
ADCTADC Therapeutics S.A.LTM Mar 2026-171.9% +25.5 pp-100.8 pp
AUTLAutolus Therapeutics plcLTM Mar 2026-311.3% +2289.7 pp+2005.7 pp
QSIQuantum-Si incorporatedLTM Mar 2026-5609.9% -2686.5 pp—
ALTAltimmune, Inc.LTM Mar 2026-253002.8% +201602.2 pp-341389.6 pp
LBRXLB Pharmaceuticals Inc Common StockFY2025— ——
SLDBSolid Biosciences Inc.FY2025— ——
AURAAura Biosciences, Inc.FY2025— ——
ANNXAnnexon, Inc.FY2025— ——
DBVTDBV Technologies S.A.FY2025— ——
RCKTRocket Pharmaceuticals, Inc.FY2025— ——
ENGNenGene Holdings Inc.FY2025— ——
Peer median (excluding QSI) -311.3%+2289.7 pp-100.8 pp

Competitors are the stored peer set for QSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue001.08M3.06M2.44M
Cost of Revenue00594K1.46M1.28M
Gross Profit00488K1.6M1.15M
Gross Margin——45.1%52.3%47.3%
Research & Development46.58M72.06M67.03M59.64M53.76M
Selling, General & Admin50.33M42.3M44.63M50.54M44.75M
Operating Expenses96.91M123.84M111.66M110.18M98.51M
Depreciation & Amortization1.04M2.58M4.16M4.6M4.45M
EBITDA(93.94M)(111.77M)(91.8M)(96.35M)(96.83M)
EBITDA Margin——-8484.7%-3150.8%-3974.8%
Operating Income(96.91M)(123.84M)(111.17M)(108.58M)(97.36M)
Operating Margin——-10274.6%-3550.6%-3996.7%
Interest Income00008.96M
Interest Expense5K0000
Other Income / Expenses1.92M(8.6M)15.21M7.63M(3.92M)
Income Before Tax(94.99M)(132.44M)(95.96M)(100.95M)(101.28M)
Pre-Tax Margin——-8868.8%-3301.2%-4157.7%
Income Tax Expense00056K58K
Net Income(94.99M)(132.44M)(95.96M)(101.01M)(101.34M)
Net Margin——-8868.8%-3303.0%-4160.1%
EPS (Basic)(1.19)(0.95)(0.68)(0.71)(0.51)
EPS (Diluted)(1.19)(0.95)(0.68)(0.71)(0.51)
Weighted Avg Shares79.58M139.26M141.3M143.2M197.77M
Weighted Avg Shares (Diluted)79.58M139.26M141.3M143.2M197.77M

Quantum-Si incorporated

NASDAQ:QSI

Intrinsic Alpha fair value

Locked

Current Price

$1.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.